All lobbying filings
BURRELL INTERNATIONAL GROUP LLC
Lobbying for TONIX PHARMACEUTICALS HOLDING CORP. · Pharmaceutical Company
Filing
4th Quarter - Report
Lobbying activity
1
LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY26 Defense Appropriation for broad-spectrum antivirals, FY26 LHHS for Long COVID and cocaine overdose funding; Alternative to Pain Act and Chronic Pain coverage